Basophil Sensitivity Increases Briefly during the Up Dosing Phase of Subcutaneous Immunotherapy.

被引:0
|
作者
Hoffmann, H. J. [1 ]
Hansen, S. [1 ]
Hansen, M. B. [1 ]
Bibby, B. M. [2 ]
Dahl, R. [1 ]
机构
[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[2] Aarhus Univ, Aarhus, Denmark
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2867
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Safety of two cluster regimens for the build-up phase of subcutaneous immunotherapy in allergic patients receiving a standardized extract of grass and olive pollen adsorbed on calcium phosphate
    Cimarra, M.
    Serrano, P.
    Martinez-Cocera, C.
    Guerra, F.
    Alva, V.
    Justicia, J.
    [J]. ALLERGY, 2007, 62 : 236 - 236
  • [42] Safety of three cluster regimens for the build-up phase of subcutaneous immunotherapy in allergic patients receiving a standardized extract of grass and olive pollen adsorbed on aluminium hydroxide
    Sanchez, C.
    Fernandez-Tavora, L.
    Serrano, P.
    Guerra, F.
    Alva, V.
    Justicia, J.
    [J]. ALLERGY, 2007, 62 : 236 - 236
  • [43] Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season
    Moesges, Ralph
    Breitrueck, Nils Y.
    Allekotte, Silke
    Shah-Hosseini, Kija
    Van-Anh Dao
    Zieglmayer, Petra
    Birkholz, Katrin
    Hess, Mark
    Bastl, Maximilian
    Bastl, Katharina
    Berger, Uwe
    Kramer, Matthias F.
    Guethoff, Sonja
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (02):
  • [44] Pollen-specific allergen immunotherapy: is it safe to initiate the build-up phase during the pollen season? Or is needed to reduce the dose?
    Gonzalez-Martin, I
    De Luque-Pinana, V
    Eguez-Hidalgo, F.
    Rubiano-Sosa, C.
    Guardia-Martinez, P.
    [J]. ALLERGY, 2012, 67 : 234 - 234
  • [45] A Streamlined Approach to Basophil Activation Testing for Longitudinal Characterization of Toddlers with Peanut Allergy During a MultiSite Phase 3 Double-Blind Placebo-Controlled Trial of Epicutaneous Immunotherapy (EPIT)
    Grishin, Alexander
    Arif-Lusson, Rihane
    Bourgoin, Penelope
    Matthews, Katie
    Campbell, Dianne
    Bahnson, Henry
    Busnel, Jean-Marc
    Sampson, Hugh
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB366 - AB366
  • [46] IMPACT OF TOLVAPTAN ON 24H-URINE VOLUME AND OSMOLALITY DURING THE UP-DOSING PHASE IN ADPKD PATIENTS: A SINGLE-CENTER STUDY
    Todorova, Polina
    Arjune, Sita
    Hendrix, Claudia
    Oehm, Simon
    Schmidt, Johannes
    Krauss, Denise
    Boehm, Volker
    Grundmann, Franziska
    Mueller, Roman-Ulrich
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I677 - I677
  • [47] Shortened immunotherapy dose-escalation saves time, but is it safe? A case-control study comparing the rates of adverse reactions between conventional and fast-escalation subcutaneous immunotherapy protocols during the induction phase
    Herrmann, Ina
    Loft, Klaus E.
    Olivry, Thierry
    [J]. VETERINARY DERMATOLOGY, 2020, 31 (06) : 454 - +
  • [48] Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children
    Dehlink, E
    Eiwegger, T
    Gerstmayr, M
    Kampl, E
    Bohle, B
    Chen, KW
    Vrtala, S
    Urbanek, R
    Szépfalusi, Z
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (01): : 32 - 39
  • [49] Immunologic Effect and Tolerability of Intra-Seasonal Subcutaneous Immunotherapy With an 8-Day Up-Dosing Schedule to 10,000 Standardized Quality-Units: A Double-Blind, Randomized, Placebo-Controlled Trial
    Pfaar, Oliver
    Wolf, Hendrik
    Klimek, Ludger
    Schnitker, Joerg
    Wuestenberg, Eike
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (10) : 2072 - 2081
  • [50] Safety of a 3-Step "Catch-Up Protocol'' in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
    Ogeer, Ijaz
    Wardha, Wardha
    Bhatt, Vaidehi
    Wu, Vince
    Hosein, Saajida
    Seto, Tyler
    Gyaltsen, Tenzin
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB248 - AB248